Hypertension is harmful to dialysis patients and should be controlled

Seminars in Dialysis

Volumn 20, Issue 6, 2007, Pages 518-522

  Foley, Robert N ^a,c   Agarwal, Rajiv ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; EPIDEMIOLOGY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; EPIDEMIOLOGIC METHODS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 35948957883     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00337.x     Document Type: Review

References (34)

1. Kannel WB : Clinical misconceptions dispelled by epidemiological research. Circulation 92 : 3350 3360, 1995
2. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. : Factors of risk in the development of coronary heart disease - six-year follow-up experience. The Framingham Study. Ann Intern Med 55 : 33 50, 1961
3. http://encarta.msn.com
4. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S : Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351 : 1755 1762, 1998
5. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G : The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330 : 877 884, 1994
6. Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C : Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension 29 : 641 650, 1997
7. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA : The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 : 584 590, 1998
8. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA : Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58 : 1325 1335, 2000
9. Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR : Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361 : 2024 2031, 2003
10. Agarwal R : Hypertension and survival in chronic hemodialysis patients - past lessons and future opportunities. Kidney Int 67 : 1 13, 2005
11. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE : Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49 : 1379 1385, 1996
12. Li Z, Lacson E Jr., Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW : The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48 : 606 615, 2006
13. Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG : Medical Directors of Dialysis Clinic Inc.: changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 17 : 513 520, 2006
14. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK : The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant 20 : 1693 1701, 2005
15. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD : Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 45 : 811 817, 2005
16. Takeda A, Toda T, Fujii T, Shinohara S, Sasaki S, Matsui N : Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 45 : 112 118, 2005
17. Agarwal R : Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis. Hemodialysis Int 8 : 207 213, 2004
18. Rahman M, Dixit A, Donley V, Gupta S, Hanslik T, Lacson E, Ogundipe A, Weigel K, Smith MC : Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 33 : 498 506, 1999
19. Fishbane S, Natke E, Maesaka JK : Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis 28 : 257 261, 1996
20. Scribner BH : Can antihypertensive medications control BP in haemodialysis patients: yes or no? Nephrol Dial Transplant 14 : 2599 2601, 1999
21. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL : Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90 : 2786 2796, 1994
22. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U : Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38 : 371 376, 2001
23. Zannad F, Kessler M, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P : Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70 : 1318 1324, 2006
24. Yu WC, Lin YP, Lin IF, Chuang SY, Chen CH : Effect of ramipril on left ventricular mass in normotensive hemodialysis patients. Am J Kidney Dis 47 : 478 484, 2006
25. Ichihara A, Hayashi M, Kaneshiro Y, Takemitsu T, Homma K, Kanno Y, Yoshizawa M, Furukawa T, Takenaka T, Saruta T : Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 45 : 866 874, 2005
26. Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T : Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron 90 : 256 261, 2002
27. Cice G, Ferrara L, D'Andrea A, D'Isa S, Di Benedetto A, Cittadini A, Russo PE, Golino P, Calabro R : Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 41 : 1438 1444, 2003
28. Cice G, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A : Dilated cardiomyopathy in dialysis patients - beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol 2001 : 37, 2001
29. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, Dohi Y : Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis - a randomized study. Nephrol Dial Transplant 2006 : 21, 2006
30. Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H, Suzuki H : Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients. J Cardiovasc Pharmacol 43 : 380 386, 2004
31. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y : A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 19 : 59 66, 2003
32. Agarwal R, Peixoto AJ, Santos SF, Zoccali C : Pre and post dialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 1 : 389 398, 2006
33. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C : Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 47 : 62 68, 2006
34. Agarwal R, Andersen MJ, Bishu K, Saha C : Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 69 : 900 906, 2006